Chapter 13. Cationic Lipid Complexes to Target Tumor Endothelium
- Dietmar W. Siemann3,4
Published Online: 31 MAY 2006
DOI: 10.1002/0470035439.ch13
Copyright © 2006 John Wiley & Sons, Ltd
Book Title
Vascular-Targeted Therapies in Oncology
Additional Information
How to Cite
Michaelis, U. and Teifel, M. (2006) Cationic Lipid Complexes to Target Tumor Endothelium, in Vascular-Targeted Therapies in Oncology (ed D. W. Siemann), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470035439.ch13
Editor Information
- 3
Shands Cancer Center, University of Florida, Gainsville, Florida, USA
- 4
Research Department of Radiation Oncology, University of Florida, 2000 RW Archer Road, Gainsville, FL 32610, USA
Publication History
- Published Online: 31 MAY 2006
- Published Print: 10 MAR 2006
ISBN Information
Print ISBN: 9780470012949
Online ISBN: 9780470035436
- Summary
- Chapter
Keywords:
- Vascular disrupting agents (VDAs);
- low-molecular-weight cytotoxic drugs;
- tumor vascular targeting and cationic liposomes;
- cationic lipid complexes targeting tumor endothelium;
- cationic liposomes as drug carriers;
- cationic lipid and gene transfer;
- chemotherapeutic drugs and proteins;
- intravenously administered cationic lipid complexes;
- cationic-liposome-based-vascular-targeting agents
Summary
This chapter contains sections titled:
Introduction
Tumor vascular targeting by cationic liposomes
Potential targets for cationic lipid complexes on tumor endothelial cells
Cationic liposomes as drug carriers
Side-effects of intravenously administered cationic lipid complexes
Preclinical data
Clinical data
Conclusion
Acknowledgments
References